Mr Martin C. Michel

KANDO id: 1031466

Bio

Martin C. Michel joined Inkef in May 2017. As physician board certified in Pharmacology and in Clinical Pharmacology, he has more than 30 years’ experience in academic and commercial drug discovery, translational pharmacology and development in Germany, the US and the Netherlands, including the discovery and clinical development of tamsulosin (Flomax®). From 2003-2011 he was Head of the Department of Pharmacology & Pharmacotherapy at the University of Amsterdam, from 2011-2016 Global Head of Product and Pipeline Scientific Support at Boehringer Ingelheim and since 2016 is Senior Partner at PAASP GmbH. His research focusses on urogenital and cardiovascular diseases, where he has published more than 500 scientific articles cited more than 21,000 times.

Career


INKEF Capital

Joint venture of OMERS and ABP
From

Education